T Cell News and Research

Latest T Cell News and Research

Study uncovers mechanisms by which microRNAs drive atherogenesis in a cell-type-specific manner

Researchers at the University of Eastern Finland have uncovered potential mechanisms by which microRNAs (miRNA) drive atherogenesis in a cell-type-specific manner.

2 Jun 2021

Could semen quality indicate SARS-CoV-2 insult susceptibility in polluted areas?

In a recent review in Environmental Science and Pollution Research, Italian researchers focused on “the evidence that correlates the degree and type of pollution with the increased susceptibility of many countries to this pandemic and proposes human semen as an early marker of the environmental health and the general health of individuals.” Their observations are based on a robust body of experimental evidence.

2 Jun 2021

Study identifies protein that could be the key to improving heart attack treatment outcomes

A new study led by researchers at Washington State University has identified a protein that could be the key to improving treatment outcomes after a heart attack.

2 Jun 2021

New vaccine candidate with RBD and N protein targets protects against SARS-CoV-2 in preclinical trials

A recent study published in the journal Science Advances, explores the immunization of RBD with the P2 epitope of tetanus toxoid, to enhance its immunogenicity, and also tests the benefit of N protein in the vaccine.

2 Jun 2021

Cmed Technology Adds More Capabilities to its Encapsia Platform and Reports Increased Demand for Use in Decentralized Trials (DCT)

Innovative technology for clinical trials is now, more than ever, necessary to deliver decentralized trials (DCT) and enable design of hybrid protocols that support trial continuity and patient-centricity.

2 Jun 2021

Can immunity form and interaction with seasonal coronaviruses influence SARS-CoV-2 epidemiology?

A new study hypothesizes that cross-protection from seasonal epidemics of HCoVs could not only affect SARS-CoV-2 transmission but also protect children from the disease.

2 Jun 2021

How antibody production in the lungs can determine severe respiratory infections

Recent findings describe how the presence of certain antibodies within the lungs can induce an immune response to minimize the effects of these infections.

2 Jun 2021

Aptamer Group and PinotBio collaborate to develop new therapeutic drug conjugates

Aptamer Group Limited and PinotBio today announce that they have entered into a strategic collaboration agreement.

From Aptamer Group 2 Jun 2021

Researchers identify new approach to clear toxic Huntingtin protein

Researchers world-wide are focused on clearing the toxic mutant Huntingtin protein that leads to neuronal cell death and systemic dysfunction in Huntington's disease (HD), a devastating, incurable, progressive neurodegenerative genetic disorder.

2 Jun 2021

Optic nerve activity may trigger the formation of vision-harming tumors in children

In a study of mice, researchers showed how the act of seeing light may trigger the formation of vision-harming tumors in young children who are born with neurofibromatosis type 1 (NF1) cancer predisposition syndrome.

2 Jun 2021

SARS-CoV-2 can be neutralized by UV-A and UV-B

Since the end of the 1800s, Ultra-violet (UV) light has been widely documented for its germicidal properties. The UV-C light produced by low-pressure mercury tubes is widely used for disinfecting wastewater, closed environments, and biological products and is well-established, safe, and economical. UV light can have a germicidal effect on bacteria and viruses.

2 Jun 2021

Natural Killer cells acts as a potential target of immunotherapy, shows study

Despite a name straight from a Tarantino movie, natural killer (NK) cells are your allies when it comes to fighting infections and cancer.

2 Jun 2021

Synthetic microRNA can serve as a novel therapeutic agent for treating human cancer

Oncotarget published "Multi-modal effects of 1B3, a novel synthetic miR-193a-3p mimic, support strong potential for therapeutic intervention in oncology" which reported that the authors comprehensively investigated miRNA-193a-3p's mode of action in a panel of human cancer cell lines, with a variety of genetic backgrounds, using 1B3, a synthetic microRNA mimic

2 Jun 2021

Scientists test antibody-based therapy to treat Crimean-Congo hemorrhagic fever virus

Army scientists working as part of an international consortium have developed and tested an antibody-based therapy to treat Crimean-Congo hemorrhagic fever virus (CCHFV), which is carried by ticks and kills up to 60 percent of those infected.

2 Jun 2021

Depleting SIRPα-deficient in macrophages activate tumor antigen-specific cytotoxic T cells

In a study that will be published in Nature Communications on May 28, 2021, a research team led by Dr. Yuan Liu from Georgia State University reports that intratumoral SIRPα-deficient macrophages activate tumor antigen-specific cytotoxic T cells to eliminate various syngeneic cancers under radiotherapy.

2 Jun 2021

Novel antibody engineering approach

Scientists from the Johns Hopkins University School of Medicine, USA, have recently developed an Antibody Display technology by grafting the second extracellular domain of tetraspanin12 (Tspan12EC2) and the receptor-binding domain (RBD) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein on the heavy chain complementarity-determining region 3 (CDR3).

2 Jun 2021

Molecular subtype of cancer preferentially affects people with Indigenous ancestry

Oncotarget published "Global DNA hypermethylation pattern and unique gene expression signature in liver cancer from patients with Indigenous American ancestry" which reported that contrasting with this pattern, the age structure of HCC in Andean people displays a bimodal distribution with half of the patients developing HCC in adolescence and early adulthood.

2 Jun 2021

Study shows how scar tissue cells in the injured heart can be converted to heart muscle cells

It is estimated that during a heart attack, one billion cells in the heart are lost. In the wake of the heart attack, the lost tissue is replaced by scar tissue, which can lead to heart failure, arrhythmia and death. In a new study, researchers from the University of Tsukuba have shown how cells in the scar tissue can be converted to heart muscle cells, effectively regenerating the injured heart.

2 Jun 2021

Researchers identify kite-shaped molecules that block SARS-CoV-2 cell entry after attachment

They have identified a group of kite-shaped compounds that are highly specific to SARS-CoV-1 and SARS-CoV-2. These compounds demonstrate high potency in inhibiting SARS-CoV-2 infection at early entry steps. The study is currently available on the bioRxiv* preprint server.

2 Jun 2021

New algorithm could be an important step toward adaptive deep brain stimulation

By delivering small electrical pulses directly to the brain, deep brain stimulation (DBS) can ease tremors associated with Parkinson's disease or help relieve chronic pain.

1 Jun 2021

T Cell News and Research

Latest T Cell News and Research

Study uncovers mechanisms by which microRNAs drive atherogenesis in a cell-type-specific manner

Could semen quality indicate SARS-CoV-2 insult susceptibility in polluted areas?

Study identifies protein that could be the key to improving heart attack treatment outcomes

New vaccine candidate with RBD and N protein targets protects against SARS-CoV-2 in preclinical trials

Cmed Technology Adds More Capabilities to its Encapsia Platform and Reports Increased Demand for Use in Decentralized Trials (DCT)

Can immunity form and interaction with seasonal coronaviruses influence SARS-CoV-2 epidemiology?

How antibody production in the lungs can determine severe respiratory infections

Aptamer Group and PinotBio collaborate to develop new therapeutic drug conjugates

Researchers identify new approach to clear toxic Huntingtin protein

Optic nerve activity may trigger the formation of vision-harming tumors in children

SARS-CoV-2 can be neutralized by UV-A and UV-B

Natural Killer cells acts as a potential target of immunotherapy, shows study

Synthetic microRNA can serve as a novel therapeutic agent for treating human cancer

Scientists test antibody-based therapy to treat Crimean-Congo hemorrhagic fever virus

Depleting SIRPα-deficient in macrophages activate tumor antigen-specific cytotoxic T cells

Novel antibody engineering approach

Molecular subtype of cancer preferentially affects people with Indigenous ancestry

Study shows how scar tissue cells in the injured heart can be converted to heart muscle cells

Researchers identify kite-shaped molecules that block SARS-CoV-2 cell entry after attachment

New algorithm could be an important step toward adaptive deep brain stimulation

Immunology eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

T Cell News and Research

Latest T Cell News and Research

Immunology eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in